PLUS THERAPEUTICS, INC. 8-K

What Happened
Plus Therapeutics, Inc. announced on January 22, 2026 that it updated its corporate presentation for use in meetings with investors, analysts and others. The company filed certain updated slides as Exhibit 99.1 to a current report on Form 8-K (Item 8.01).

Key Details

• Filing date: January 22, 2026 (Form 8-K, Item 8.01).
• Exhibit filed: Exhibit 99.1 — Investor Presentation as of January 22, 2026.
• Purpose: Updated slides intended for meetings with investors, analysts and other stakeholders.
• No financial results or executive changes were reported in this filing.

Why It Matters
An updated investor presentation can include refreshed strategic priorities, program updates, timelines or scientific/clinical data that may be material to investors. While this 8-K does not report earnings, personnel changes or transactions, shareholders and prospective investors should review the Exhibit 99.1 slides (available on the SEC EDGAR site or the company’s investor relations page) to see if there are new disclosures relevant to their investment decisions.